Skip to content
Close
About
Governance Board
Advisory Board
Membership
Careers
Funding
CER Awards
Contact
Staff
Global Calendar
News
Announcements
Weekly View
Blog
Journal Articles
Home
Programs
CTAF
Midwest CEPAC
New England CEPAC
Choosing Wisely®
Proven Best Choices
®
Patient Materials
Topics
Materials
Meetings
Methodology
How we do our work
Patient, Manufacturer, and Other Stakeholder Engagement
Policies that guide our work
Menu
Close
Programs
CTAF
Midwest CEPAC
New England CEPAC
Choosing Wisely®
Patient Materials
Proven Best Choices
®
Topics
Materials
Meetings
Methodology
How we do our work
Patient, Manufacturer, and Other Stakeholder Engagement
Policies that guide our work
About
Governance Board
Advisory Board
Membership
Careers
Funding
CER Awards
Contact
Staff
Global Calendar
News
Announcements
Weekly View
Blog
Journal Articles
Blog
New and Noteworthy in July
06/30/2017
ICER’s Drug Pricing Work Featured in Wired
06/14/2017
New and Noteworthy in June
06/01/2017
New and Noteworthy in May
04/28/2017
New and Noteworthy in April
03/31/2017
New and Noteworthy in March
03/01/2017
Survey Highlights Health Plan Use of ICER Reports
02/08/2017
New and Noteworthy in February
01/31/2017
Including the Patient Perspective
01/04/2017
New and Noteworthy in January
01/02/2017
To ensure that our reports are as useful as possible to our stakeholders, we would like to get a better sense of how they are being used. You will be redirected to the report after answering these brief questions.
Which category best describes your perspective?
*
Select One
Academic/Researcher
Clinical Society
Employer/Purchaser
Health Care Provider
Hospital/Provider Organization/ACO
Life Sciences Manufacturer
Media
Patient/Consumer
Policymaker/Government Official
Private Payer/PBM
Public Payer
Other
Other
How do you intend to use this material
*
Please check all that apply.
To inform treatment decisions or guidelines
To inform state policy
To inform federal policy
To inform public comment/feedback to ICER
To inform coverage decisions and contracting policies
To inform pricing
Other
If Other, please describe
